Breast cancer tumor histopathology, stage at presentation, and treatment in the extremes of age
- 24 January 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 180 (1), 227-235
- https://doi.org/10.1007/s10549-020-05542-4
Abstract
Background Given presumed differences in disease severity between young (≤ 45 years) and elderly (≥ 75 years) women with breast cancer, we sought to compare tumor histopathology, stage at presentation, patterns of care, and survival at the extremes of age. Methods Adults with stages 0–IV breast cancer in the National Cancer Database (2004–2015) were categorized by age (18–45 years, 46–74 years, ≥ 75 years) and compared. Kaplan–Meier curves were used to visualize unadjusted overall survival (OS). A Cox proportional-hazards model was used to estimate the effect of age group, including adjustment for tumor subtype [hormone receptor [HR]+/HER2−, HER2+, triple-negative (TN)]. Results Of the 1,201,252 patients identified, 13% were ≤ 45 years and 17.5% were ≥ 75 years. Women ≤ 45 years were more likely to have higher pT/N stages and grade 3 disease compared to older patients; however, rates of de novo cM1 disease were comparable (3.7% vs 3.5%). HER2+ and TN tumors were more common in those ≤ 45 years (HER2+ : 18.6% vs 9.2%; TN: 14.9% vs 8.2%), while HR+/HER2− tumors were more likely in women ≥ 75 years (69.3% vs 51.3%) (all p < 0.001). Younger patients were more likely to undergo mastectomy vs lumpectomy (56% vs 34%), and receive chemotherapy (65.8% vs 10.2%) and radiation (56.2% vs 39.5%). After adjustment, OS was worse in older patients (older HR 2.94, CI 2.86–3.03). Conclusions High-risk tumor subtypes and comprehensive multimodal treatment remain significantly more common among younger women (≤ 45 years) with breast cancer, yet, elderly women are similarly diagnosed with incurable de novo metastatic disease. Tailored screening and treatment strategies are critical to prevent age-related disparities in breast cancer care.Keywords
Funding Information
- National Institutes of Health (K12HD043446-11, 1K08CA241390, P30-CA014236)
This publication has 25 references indexed in Scilit:
- Axillary Nodal Evaluation in Elderly Breast Cancer Patients: Potential Effects on Treatment Decisions and SurvivalAnnals of Surgical Oncology, 2018
- Factors Associated with Recurrence Rates and Long-Term Survival in Women Diagnosed with Breast Cancer Ages 40 and YoungerAnnals of Surgical Oncology, 2016
- Management of breast cancer in very young womenThe Breast, 2015
- Approach and Management of Breast Cancer in the ElderlyClinics in Geriatric Medicine, 2015
- Biology of breast cancer in young womenBreast Cancer Research, 2014
- Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343Journal of Clinical Oncology, 2013
- Occurrence of breast cancer subtypes in adolescent and young adult womenBreast Cancer Research, 2012
- Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression ProfilingClinical Cancer Research, 2012
- Therapeutic management of breast cancer in the elderlyExpert Opinion on Pharmacotherapy, 2011
- Does primary breast cancer in older women (≥80 years) have unfavorable histological characteristics?Archiv für Gynäkologie, 2010